Asia Pacific Clot Management Devices Market By Product Type (Percutaneous Thrombectomy Devices, Embolectomy Balloon Catheters, Catheter-Directed Thrombolysis devices, Neurovascular Embolectomy Devices), End User (Hospitals, Diagnostic Centers)
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the Asia Pacific Clot Management Devices Market
Blood Clotting also known as coagulation is the body's response to an injury to prevent bleeding. However, a clot can be harmful when it forms abnormal flows through the vessels. The excessive formation of clots in the blood leads to different diseases such as brain stroke, heart attack and severe leg pain. Rising incidences of Heart failure, Brain disorder and other clot related problems have initiated the organizations to take measures against the problem.
Clot management devices are one of the major treatments available in the market. The affordability and rising awareness would ultimately enhance the market for clot management devices market. Based on the report by Australian bureau of National Health Survey, In 2014-2015, an estimated 645,000 Australians aged 18 and above had Cardiovascular Disease Increased with age half (53%) of 65-74-year-olds and two-thirds (66%) of those aged 75+ had Cardiovascular Diseases. Asia-Pacific with increasing per capita income and high economic potentials would emerge as a prominent market during the forecast period.
Based on the product type, the Clot Management Devices market is segmented into Percutaneous Thrombectomy Devices, Embolectomy Balloon Catheters, Catheter-Directed Thrombolysis (CDT) devices, Neurovascular Embolectomy Devices and Inferior vena cava filters. Based on End user Type, the market is segmented into Hospitals and Diagnostic Centres. Based on Country, Asia-Pacific Clot Management Devices market is segmented into China, Japan, India, South Korea, Singapore, Malaysia and Rest of Asia-Pacific.
China remained the dominant Country in the Asia-Pacific Clot Management Devices market in 2015. India and South Korea would witness promising CAGR during the forecast period (2016-2022). The report covers the analysis of key stake holders of the Clot Management Devices market. Key companies profiled in the report include Teleflex Inc., Edwards Lifesciences Corporation, Medtronic Plc, Boston Scientific Corporation, Lemaitre Vascular, Inc., Straub Medical AG, Cook Medical Inc. and Johnson & Johnson.